Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-380P, or RNA, U6 small nuclear 380, pseudogene, is classified as a pseudogene related to the U6 small nuclear RNA (snRNA) family. The functional U6 snRNA is a highly conserved non-coding RNA that is fundamental to the spliceosome, the molecular machinery responsible for removing introns from pre-mRNA during RNA splicing[1][3]. The U6 snRNA is essential for spliceosome catalysis, directly coordinating catalytic metal ions and forming part of the spliceosomal active site[1][3]. However, by definition, a pseudogene such as RNU6-380P is a genomic sequence similar to a functional gene but is generally nonfunctional due to mutations, deletions, or lack of proper regulatory elements[5]. Pseudogenes like RNU6-380P do not produce functional snRNA molecules and are not known to have a direct role in RNA splicing or other biological processes. They are not considered therapeutic targets, and there is no evidence linking RNU6-380P to disease mechanisms, drug interactions, or biomarker utility. The presence of U6 snRNA pseudogenes in the genome highlights the evolutionary importance of U6 but does not ascribe functional or therapeutic significance to these specific pseudogenes[3][5]. If you are seeking information on the canonical, functional U6 snRNA, it should be distinguished from its pseudogenes[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 380, pseudogene (RNU6-380P).